Imperative Care Announces Appointment of Brian Armijo as Vice President of Operations

Company Also Expands Sales Team to Include Five Leaders with Extensive Neurovascular Experience

CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., a company singularly dedicated to answering unsolved problems in stroke, today announced that Brian Armijo has been appointed as vice president of operations. With more than 25 years of manufacturing and operations experience and leadership and an extensive background in the cardiovascular space, Armijo brings significant relevant expertise in scaling operations to support the commercialization of products used in life-saving medical interventions. The company also announced it has expanded its sales force to include five new team members with deep neurovascular experience.

Armijo most recently served as senior vice president of operations at RODO Medical, a company focused on developing devices for implant dentistry. He also spent nine years as vice president and senior vice president of operations with AccessClosure, Inc. Armijo oversaw the company’s operations team and effectuated a significant in-house scale up of production to over a half-million units annually. He has also successfully built and led operations at several other medical device companies, including Boston Scientific, Embolic Protection, Inc., Quanam Medical, Somnus Medical Technologies and ArthroCare.

“At Imperative Care, we have invested a significant amount of focus on convening a seasoned bench of leaders, furthering the enduring mission of the company,” said Fred Khosravi, Imperative Care’s founding chairman and CEO, and the co-founder and co-managing director of Incept LLC. “With the addition of Brian Armijo as vice president of operations and several new sales team members with deep neurovascular experience, we continue to strengthen the commercial and operational disciplines of Imperative Care in support of the company’s core aim of elevating stroke care.”

“I am thrilled to be joining Imperative Care at this very exciting time in the company’s growth,” said Brian Armijo. “Imperative Care is developing a portfolio of stroke treatment products with the goal of improving stroke outcomes. It is an honor to have the opportunity to lead operations and expand access to products designed to help give stroke patients the best chance at an optimal recovery.”

Imperative Care is co-founded by Dr. Nick Hopkins, a pioneer of endovascular neurointervention and Founder and Chief Scientific Officer of Jacobs Institute, and Fred Khosravi, a medtech entrepreneur who has founded more than 20 companies. The company is the twenty-first start-up instituted by Khosravi via Incept LLC, a medical technology accelerator and development company that has successfully innovated various medical technologies that treat more than a million patients a year globally.

About Imperative Care, Inc.

Based in Campbell, Calif., Imperative Care is speeding new answers to stroke by developing a portfolio of innovative solutions to address the vast and urgent unmet needs in stroke care. The company is singularly dedicated to improving the way stroke is treated by advancing medical technology, equipping healthcare providers to evolve best practices and elevate the standard of care for stroke patients. For more information, visit http://www.imperativecare.com/.

Contacts

Jana Chow

Jana@healthandcommerce.com
925-324-9846

Staff

Recent Posts

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

6 minutes ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

6 minutes ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

1 hour ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago